EBS compared with PBYI: revenue, margins and what each company keeps, and the suppliers and customers both name

EBSEmergent BioSolutions Inc.

Mkt capRevenueRevenue

PBYIPuma Biotechnology, Inc.

Mkt capRevenueRevenue

Compare

EBSEmergent BioSolutions Inc.

PBYIPuma Biotechnology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 499dMethod ›

Moved together

EBSwithPBYI

×0.22co-movement · PBYI on EBS · 499d

r 0.28scale to r 0.75

No shared co-movers.

EBS, solidPBYI, hatched× = co-movement · βr = correlationBar = r to r 0.75Source: daily closes

EBSEmergent BioSolutions Inc.

6.79· pre 6.79· delayed

Mkt cap$349.2MRevenue$234MQ2 FY26Revenue$743MFY25

PBYIPuma Biotechnology, Inc.

10.42· pre 10.43· delayed

Pre-marketOct 30 '26delayed

Mkt cap$538.9MRevenue$57MQ2 FY26Revenue$228MFY25

Compare

Pre-marketOct 30 '26delayed

EBSEmergent BioSolutions Inc.

PBYIPuma Biotechnology, Inc.

6.79pre 6.79delayed

Price

10.42pre 10.43delayed

$349.2M

Mkt cap

$538.9M

Q2 FY26$234M

Revenue

$57MQ2 FY26

FY25$743M

Revenue

$228MFY25

EBS6.79vsPBYI10.42Pre-marketOct 30 '26delayed